ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves HETLIOZ for Nighttime Sleep Disturbances in Smith-Magenis Syndrome
December 22, 2020Vanda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with nighttime sleep disturbances associated with ... -
Vanda Announces Positive Study Results for Hetlioz
December 11, 2018Vanda announced Hetlioz (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical study.... -
Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag
March 06, 2018Vanda Pharmaceuticals, Inc., based in Washington, D.C., announced positive results from its JET8 Phase III clinical trial of Hetlioz for jet lag disorder.
Pharma Sources Insight January 2025
